Article
Phenotypic enhancement of thymidylate synthetase pathway inhibitors following ablation of Neil1 DNA glycosylase/lyase.
Cell cycle (Georgetown, Tex.) - 15 Dec 2010
Taricani Lorena, Shanahan Frances, Pierce Rob H, Guzi Timothy J, Parry David
Abstract excerpt
Inhibition of thymidine biosynthesis is a clinically-validated therapeutic approach for multiple cancers. Inhibition of thymidylate synthetase (TS) leads to a decrease in cellular TTP levels, replication stress and increased genomic incorporation of uridine (dUMP). Thus, inhibitors of this pathwa...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
